Angola vs Venezuela, Bolivarian Republic of: Immunization, HepB3
Angola
64.0%
in 2024
Venezuela, Bolivarian Republic of
62.0%
in 2024
Angola rank
173rd
Venezuela, Bolivarian Republic of rank
176th
Immunization, HepB3 over time
- Angola
- Venezuela, Bolivarian Republic of
How they compare
Angola currently reports 64.0% against 62.0% in Venezuela, Bolivarian Republic of, a difference of 2.0%.
The two have swapped places 5 times across 18 shared years of data; in 2007 it was Venezuela, Bolivarian Republic of ahead.
Angola ranks 173rd and Venezuela, Bolivarian Republic of ranks 176th of 188 countries.
Across the 3 decades both report, Angola averaged higher in 1 and Venezuela, Bolivarian Republic of in 2.
Head to head by decade
| Decade | Angola | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.0% | 66.3% | 21.3% | Venezuela, Bolivarian Republic of |
| 2010s | 56.5% | 75.8% | 19.3% | Venezuela, Bolivarian Republic of |
| 2020s | 59.6% | 53.8% | 5.8% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Angola or Venezuela, Bolivarian Republic of?
- Angola, at 64.0% against 62.0% in Venezuela, Bolivarian Republic of as of 2024.
- What is the difference in immunization, hepb3 between Angola and Venezuela, Bolivarian Republic of?
- 2.0%, with Angola ahead.
- How many years of comparable data are there for Angola and Venezuela, Bolivarian Republic of?
- 18 years are reported by both, from 2007 to 2024.
- How do Angola and Venezuela, Bolivarian Republic of rank globally for immunization, hepb3?
- Angola ranks 173rd and Venezuela, Bolivarian Republic of ranks 176th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.